Skip to main content

Table 3 Secondary outcome measures in the BIG group: comparison to baseline

From: LSVT-BIG therapy in Parkinson’s disease: physiological evidence for proprioceptive recalibration

Measure (ANOVARM) D1 D2 § D3 §
MDS-UPDRS III (F(2;20) = 3.2, p = 0.061) 22.3 ± 12.3 18.3 ± 9.3 17.8 ± 10.5
PDQ-39 (F(2;20) = 4.6, p = 0.043*) 19.3 ± 10.3 13.8 ± 6.5 (p = 0.016*) 12.1 ± 8.6 (p = 0.052)
NHPT [s] (F(2;20) = 3.2, p = 0.063) 25.3 ± 3.3 23.5 ± 4.3 23.5 ± 2.6
  1. MDS-UPDRS III motor subscale of the MDS Unified Parkinson’s Disease Rating Scale, PDQ Parkinson’s Disease Questionnaire, NHPT nine-hole-peg test, ANOVARM = p-values for repeated measures ANOVA
  2. § p-values for post-hoc analysis (compared to baseline), only given in case of significant ANOVA result